Sale!

ATP1A2 Gene Familial Hemiplegic Migraine Type 2 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The ATP1A2 Gene Familial Hemiplegic Migraine Type 2 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the ATP1A2 gene responsible for familial hemiplegic migraine type 2. This neurological disorder causes severe migraine attacks accompanied by temporary paralysis on one side of the body. Using Next Generation Sequencing technology, the test provides comprehensive analysis of the ATP1A2 gene to detect pathogenic variants that disrupt normal brain function. The test is particularly valuable for individuals with family history of hemiplegic migraines or those experiencing unexplained neurological symptoms. Results help guide treatment decisions, inform family planning, and provide clarity about inheritance patterns. The test costs $500 USD and is available at our nationwide locations with genetic counseling support included.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

ATP1A2 Gene Familial Hemiplegic Migraine Type 2 NGS Genetic DNA Test

Comprehensive Genetic Analysis for Hereditary Migraine Disorders

The ATP1A2 Gene Familial Hemiplegic Migraine Type 2 NGS Genetic DNA Test represents a significant advancement in neurological genetic diagnostics. This specialized test focuses on identifying mutations in the ATP1A2 gene, which encodes a critical sodium-potassium pump subunit essential for maintaining proper brain function and neuronal signaling. Familial hemiplegic migraine type 2 is a rare autosomal dominant neurological disorder characterized by severe migraine attacks accompanied by temporary motor weakness or paralysis.

What This Test Measures and Detects

This comprehensive genetic analysis utilizes Next Generation Sequencing (NGS) technology to examine the entire coding region of the ATP1A2 gene. The test specifically identifies:

  • Pathogenic variants and mutations in the ATP1A2 gene
  • Single nucleotide polymorphisms associated with familial hemiplegic migraine
  • Deletions, insertions, and other structural variations
  • Missense, nonsense, and frameshift mutations affecting protein function
  • Genetic markers that disrupt sodium-potassium ATPase activity in brain cells

Who Should Consider This Test

This genetic test is recommended for individuals experiencing:

  • Recurrent migraine attacks with temporary paralysis or weakness on one side of the body
  • Family history of hemiplegic migraines or unexplained neurological disorders
  • Migraine episodes accompanied by visual disturbances, speech difficulties, or sensory changes
  • Unexplained neurological symptoms that don’t respond to conventional migraine treatments
  • Planning for pregnancy with concerns about hereditary neurological conditions
  • Children or adolescents with atypical migraine presentations

Clinical Benefits of Genetic Testing

Undergoing the ATP1A2 genetic test provides numerous clinical advantages:

  • Accurate Diagnosis: Confirms or rules out familial hemiplegic migraine type 2 with high precision
  • Personalized Treatment: Enables targeted therapeutic approaches based on genetic findings
  • Family Planning Guidance: Provides information about inheritance patterns and recurrence risks
  • Early Intervention: Facilitates proactive management strategies for at-risk family members
  • Symptom Management: Helps develop effective prevention and treatment protocols
  • Genetic Counseling: Supports informed decision-making about reproductive choices

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our team of certified genetic counselors and neurologists:

  • Positive Result: Indicates the presence of a pathogenic ATP1A2 mutation, confirming familial hemiplegic migraine type 2 diagnosis
  • Negative Result: Suggests no detectable mutation in the ATP1A2 gene, though other genetic or non-genetic causes should be considered
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications requiring further evaluation
  • Carrier Status: Determines if you carry the mutation and potential risk of passing it to offspring

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We have conveniently located testing centers across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality genetic testing services with comprehensive support from initial consultation through result interpretation.

Schedule Your Genetic Test Today

Take the first step toward understanding your neurological health and genetic predisposition. Our experienced team of genetic counselors and neurologists are ready to guide you through the testing process and provide personalized insights into your results. Contact us today to schedule your appointment and begin your journey toward better neurological health management.

Call or WhatsApp: +1(267) 388-9828 to book your ATP1A2 Gene Familial Hemiplegic Migraine Type 2 NGS Genetic DNA Test today. Our genetic specialists are available to answer your questions and help you understand how this advanced testing can benefit your neurological health journey.